Rebif

Type: Product

Name: Rebif

First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

Is Rebif Right for You?

If you are considering Rebif as your multiple sclerosis disease-modifying therapy, you need to know the facts about Rebif side effects, efficacy, cost, contraindications, convenience and other practical matters to help you make your decision. Learn more ... [Published About.com Multiple Sclerosis: Most Popular Arti ... - Jun 11 2013]

Entities: Rebif, Multiple Sclerosis

First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

Is Rebif Right for You? (continued)

Entities: Rebif, Multiple Sclerosis

First reported Jun 11 2013 - Updated Jun 11 2013 - 1 reports

Neutralizing Antibodies and Disease-Modifying...

In multiple sclerosis (MS), neutralizing antibodies are often produced by the immune system in response to interferon-based treatments for MS, including Avonex, Rebif and Betaseron. These antibodies can lessen the effects of the treatment. ... [Published About.com Multiple Sclerosis: Most Popular Arti ... - Jun 11 2013]

Entities: Neutralization, Multiple Sclerosis, Antibody, Betaseron

First reported Jun 03 2013 - Updated Jun 03 2013 - 1 reports

PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022

Summary "". Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current ... [Published Individual.com - Jun 03 2013]

Entities: Multiple Sclerosis, market analysis, Japan, Drugs

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Just Released: "Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022"

3 Comments, last updated on Tuesday May 21 by Vaccines Cause MS ... [Published Topix Forum MS - May 21 2013]

Entities: Rebif, Multiple Sclerosis, market analysis

First reported May 14 2013 - Updated May 14 2013 - 1 reports

REBIF (Interferon Beta-1a) Kit REBIF REBIDOSE (Interferon Beta-1a) Kit REBIF (Interferon Beta-1a ) Injection, Solution REBIF (Interferon Beta-1a) Injection, Solution REBIF REBIDOSE (Interferon Beta-1a ) Injection, Solution [EMD Serono, Inc.]

Updated Date: May 8, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]

Entities: Rebif, Interferon Beta-1a, RebiDose

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Rating Your MS Patient Support Program

Living with MS presents people with many challenges and a person’s needs for information, counselling and support evolve over the years. All of the companies that manufacture MS medications provide patient support programs (PSPs) to provide information ... [Published MSology - May 09 2013]

Entities: Patient, Extavia, Betaseron

First reported May 09 2013 - Updated May 09 2013 - 1 reports

REBIF (Interferon Beta-1a) Kit REBIF REBIDOSE (Interferon Beta-1a) Kit REBIF (Interferon Beta-1a ) Injection, Solution REBIF (Interferon Beta-1a) Injection, Solution REBIF REBIDOSE (Interferon Beta-1a ) Injection, Solution [EMD Serono, Inc.]

Updated Date: May 8, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]

Entities: Rebif, Interferon Beta-1a, RebiDose

First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

A Quick Pronunciation Guide to Some MS Medications

Back when there was Copaxone, Rebif, Avonex and Betaseron, things were pretty easy to pronounce (although my nurse kept referring to my "Copazone" injection when she was teaching me how to give myself a shot). ... Read Full Post ... [Published About.com Multiple Sclerosis - Apr 30 2013]

Entities: Betaseron, Avonex, Rebif, Copaxone

First reported Apr 18 2013 - Updated Apr 18 2013 - 1 reports

Human medicines European Public Assessment Report (EPAR): Rebif, interferon beta-1a, Revision: 25, Authorised

[Published Pending EC decisions and European Public Assess ... - Apr 18 2013]

Entities: Rebif, Interferon Beta-1a

First reported Jan 04 2013 - Updated Jan 05 2013 - 2 reports

US FDA approves Rebif Rebidose, a single-use auto-injector for self-administration of Rebif

The US Food and Drug Administration (FDA) has approved Rebif Rebidose (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS)."We are pleased ... [Published PharmaBiz - Jan 05 2013]

Entities: Rebif, Multiple Sclerosis, Multiple Sclerosis Therapy

First reported Jan 03 2013 - Updated Jan 04 2013 - 2 reports

FDA approves EMD-Pfizer multiple sclerosis therapy

EMD Serono, a subsidiary of Merck, and Pfizer have announced the FDA approval of Rebif Rebidose (interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis (MS). ... [Published PBR - News - Jan 04 2013]

Entities: Multiple Sclerosis, Rebif, EMD Serono, Interferon Beta-1a

Quotes

"We don't have a big company in pharma from whom you can learn the processes required in R&D, clinical trials and regulatory, so people are finding their way on their own" Alon said ahead of an annual biomed conference that she co-chairs

ANALYSIS-After tech success, Israel seeks life sciences growth [Published CNBC - Jun 06 2013]

Krieger S, et al. "Alemtuzumab is efficacious in highly-active RRMS patients in CARE-MS II" CMSC-ACTRIMS 2013; Abstract DX01

Highly Active MS Falls to Novel Drug (CME/CE) [Published MedPage Today - Jun 01 2013]

...that difficulties with managed care coverage of Aubagio may be having a trickle-down effect on neurologists' perception of Aubagio's price. "Given that neurologists report currently treating 9 percent of their DMA-treated RR-MS patients with the oral DMAs available at the time of survey fielding (Aubagio and Gilenya), it is interesting to note that surveyed neurologists expect the oral DMA group to capture 23 percent patient share over the next six months" said BioTrends Research Group Analyst Emma Williams

For Multiple Sclerosis Treatment, Prescriber Base for Genzyme's Aubagio Among U.S. Neurologists H ... [Published ADVFN UK - May 30 2013]

...Nurse Support Network, MS LifeLines Ambassadors and patient education programs," said Liz Barrett, President, North America, Pfizer Specialty Care. "We look forward to continuing our commitment to excellence in the services we provide to the MS community."

MS LifeLines Call Center Earns Re-Certification for Excellence [Published ContactCenterWorld.com - May 29 2013]

More Content

sort by: Date \| Relevance
2 Healthcare Companies With Recent Intensive In... [Published Seeking Alpha - Jun 13 2013]
Neutralizing Antibodies and Disease-Modifying... [Published About.com Multiple Sclerosis: Most Popular Arti ... - Jun 11 2013]
Is Rebif Right for You? (continued) [Published About.com Multiple Sclerosis: Most Popular Arti ... - Jun 11 2013]
Is Rebif Right for You? [Published About.com Multiple Sclerosis: Most Popular Arti ... - Jun 11 2013]
Early diagnosis and treatment may reduce MS rel... [Published Del Mar Times - Jun 09 2013]
ANALYSIS-After tech success, Israel seeks life ... [Published CNBC - Jun 06 2013]
PharmaPoint: Multiple Sclerosis - Japan Drug Fo... [Published Individual.com - Jun 03 2013]
Highly Active MS Falls to Novel Drug (CME/CE) [Published MedPage Today - Jun 01 2013]
MRI Findings Drive Tx Changes in MS [Published MedPage Today - May 31 2013]
For Multiple Sclerosis Treatment, Prescriber Ba... [Published ADVFN UK - May 30 2013]
MS LifeLines Call Center Earns Re-Certification... [Published ContactCenterWorld.com - May 29 2013]
Report Published: "BG-12 (Multiple Sclerosis) -... [Published Live-PR.com - May 24 2013]
Report Published: "NU-100 (Multiple Sclerosis) ... [Published Live-PR.com - May 24 2013]
Market Report, "Masitinib (Multiple Sclerosis) ... [Published Live-PR.com - May 24 2013]
Patent Issued for Use of Gelsolin to Treat Mult... [Published Equities.com - May 22 2013]
PharmaPoint: Multiple Sclerosis - Canada Drug F... [Published Individual.com - May 22 2013]
Biogen Idec seeking approval from the FDA for a... [Published Boston Globe - May 21 2013]
Just Released: "Rebif (Multiple Sclerosis) - Fo... [Published Topix Forum MS - May 21 2013]
PharmaPoint: Multiple Sclerosis - Germany Drug ... [Published Individual.com - May 21 2013]
Johnson & Johnson and Merck Lead the Dow Health... [Published Wall St. Cheat Sheet - May 19 2013]
Global Multiple Sclerosis Drugs Market Research... [Published PR.com Press Releases - May 17 2013]
JPMorgan Market Revenue Soars Year-Over-Year an... [Published Wall St. Cheat Sheet - May 14 2013]
Research and Markets: Rebif (Multiple Sclerosis... [Published Business Wire Health News - May 14 2013]
REBIF (Interferon Beta-1a) Kit REBIF REBIDOSE (... [Published DailyMed Drug Label Updates for the last seven ... - May 14 2013]
Rating Your MS Patient Support Program [Published MSology - May 09 2013]
REBIF (Interferon Beta-1a) Kit REBIF REBIDOSE (... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]
Migraine common in MS [Published MSology - May 02 2013]
A Quick Pronunciation Guide to Some MS Medications [Published About.com Multiple Sclerosis - Apr 30 2013]
How is MS different in blacks? [Published MSology - Apr 25 2013]
Human medicines European Public Assessment Repo... [Published Pending EC decisions and European Public Assess ... - Apr 18 2013]